Avrobio | Nettoindtægt

Net Income Lave om Dato
Adcock Ingram Holdings ZAR 430.06M 38.29M 2023-06
Alnylam Pharmaceuticals USD -65935000 71.94M 2024-03
Ecofibre AUD -22305000 4.7M 2023-06
Gilead Sciences USD -4170000000 5.6B 2024-03
Ionis Pharmaceuticals USD -142803000 133.54M 2024-03
Kangmei Pharma CNY -22150950 53.3M 2023-09
Knight Therapeutics CAD 9.59M 7.75M 2023-09
Laboratorios Farma EUR 66.65M 52.4M 2023-06
Malin Corporation EUR 1.1M 10.6M 2023-06
Medical Developments International AUD -8267000 10.92M 2023-06
Neuren Pharmaceuticals AUD 47.8M 40.57M 2023-06
Organigram Holdings CAD -213451000 205.96M 2023-03
Pfizer USD 3.12B 6.48B 2024-03
Pharma Mar EUR 1.52M 3.5M 2023-09
Probiotec AUD 5.56M 96.63K 2023-06
Qiagen NV USD 80.67M 16.99M 2024-03
Roche Holding CHF 7.14B 3.25B 2023-06
Sarepta Therapeutics USD 36.12M 77.06M 2024-03
Sartorius EUR 36.7M 28.4M 2024-03
Sino Biopharmaceutical CNY 1.26B 636.25M 2023-06
Takeda JPY 105.72B 153.75B 2023-12
Zz Pientze Pharmaceu 863.81M 92.66M 2023-09



Avrobio Nettoindtægt - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Jun 2024.